Register now for the Microbiome Function Analysis webinar on Feb 19

White Paper

Global metabolomics, when applied to Parkinson’s Disease research, has the potential to make a significant impact in biomarker development, whether for susceptibility, diagnosis, pharmacodynamic response or prognostic assessment of disease. And even beyond biomarkers, Next- Generation Metabolomics from Panome Bio opens doors to understanding molecular mechanisms and signaling pathways involved in PD.

The Metabolomics of Parkinson’s Disease

Download Now


Your privacy is important to us.
We’ll never share your information.

Skip to content